4.8 Article

Bioinspired drug-delivery system emulating the natural bone healing cascade for diabetic periodontal bone regeneration

Journal

BIOACTIVE MATERIALS
Volume 21, Issue -, Pages 324-339

Publisher

KEAI PUBLISHING LTD
DOI: 10.1016/j.bioactmat.2022.08.029

Keywords

Periodontal bone regeneration; Diabetes mellitus; Bioinspired; Hydrogel; Drug delivery

Ask authors/readers for more resources

Researchers have designed a bioinspired drug-delivery system for diabetic periodontal bone regeneration. The system emulates the natural bone healing cascade by releasing drugs and recruiting stem cells to promote bone regeneration. In vitro and in vivo experiments have shown that the system is effective in restoring bone healing in diabetic patients.
Diabetes mellitus (DM) aggravates periodontitis, resulting in accelerated periodontal bone resorption. Disordered glucose metabolism in DM causes reactive oxygen species (ROS) overproduction resulting in compromised bone healing, which makes diabetic periodontal bone regeneration a major challenge. Inspired by the natural bone healing cascade, a mesoporous silica nanoparticle (MSN)-incorporated PDLLA (poly(DL-lactide))-PEG-PDLLA (PPP) thermosensitive hydrogel with stepwise cargo release is designed to emulate the mesenchymal stem cell recruitment-osteogenesis cascade for diabetic periodontal bone regeneration. During therapy, SDF-1 quickly escapes from the hydrogel due to diffusion for early rat bone marrow stem cell (rBMSC) recruitment. Simulta-neously, slow degradation of the hydrogel starts to gradually expose the MSNs for sustained release of metformin, which can scavenge the overproduced ROS under high glucose conditions to reverse the inhibited osteogenesis of rBMSCs by reactivating the AMPK/beta-catenin pathway, resulting in regulation of the diabetic microenvironment and facilitation of osteogenesis. In vitro experiments indicate that the hydrogel markedly restores the inhibited migration and osteogenic capacities of rBMSCs under high glucose conditions. In vivo results suggest that it can effectively recruit rBMSCs to the periodontal defect and significantly promote periodontal bone regeneration under type 2 DM. In conclusion, our work provides a novel therapeutic strategy of a bioinspired drug-delivery system emulating the natural bone healing cascade for diabetic periodontal bone regeneration.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available